de Morgan Stanley PTC Therapeutics PTCT Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 90 M | Comprar |
1,103,675
+429,541
| +64% | +USD 31 M | ﹤0.01% | 1664 |
|
|
2026
Q1 | USD 45.9 M | Vender |
674,134
-231,058
| -26% | -USD 16.4 M | ﹤0.01% | 2189 |
|
|
2025
Q4 | USD 68.8 M | Comprar |
905,192
+485,775
| +116% | +USD 35.3 M | ﹤0.01% | 1771 |
|
|
2025
Q3 | USD 25.7 M | Vender |
419,417
-743,922
| -64% | -USD 38.7 M | ﹤0.01% | 2648 |
|
|
2025
Q2 | USD 56.8 M | Comprar |
1,163,339
+213,905
| +23% | +USD 10.2 M | ﹤0.01% | 1806 |
|
|
2025
Q1 | USD 48.4 M | Vender |
949,434
-124,383
| -12% | -USD 6.21 M | ﹤0.01% | 1850 |
|
|
2024
Q4 | USD 48.5 M | Vender |
1,073,817
-84,237
| -7% | -USD 3.61 M | ﹤0.01% | 1861 |
|
|
2024
Q3 | USD 43 M | Vender |
1,158,054
-358,703
| -24% | -USD 12 M | ﹤0.01% | 1976 |
|
|
2024
Q2 | USD 46.4 M | Vender |
1,516,757
-546,284
| -26% | -USD 17.7 M | ﹤0.01% | 1833 |
|
|
2024
Q1 | USD 60 M | Comprar |
2,063,041
+816,782
| +66% | +USD 22.9 M | ﹤0.01% | 1594 |
|
|
2023
Q4 | USD 34.3 M | Comprar |
1,246,259
+810,519
| +186% | +USD 18.5 M | ﹤0.01% | 2119 |
|
|
2023
Q3 | USD 9.8 M | Comprar |
435,740
+54,664
| +14% | +USD 2.03 M | ﹤0.01% | 3148 |
|
|
2023
Q2 | USD 15.5 M | Comprar |
381,076
+155,186
| +69% | +USD 7.59 M | ﹤0.01% | 2732 |
|
|
2023
Q1 | USD 10.9 M | Vender |
225,890
-71,775
| -24% | -USD 3.28 M | ﹤0.01% | 3058 |
|
|
2022
Q4 | USD 11.4 M | Comprar |
297,665
+13,416
| +5% | +USD 558 k | ﹤0.01% | 2949 |
|
|
2022
Q3 | USD 14.3 M | Vender |
284,249
-140,138
| -33% | -USD 6.87 M | ﹤0.01% | 2581 |
|
|
2022
Q2 | USD 17 M | Comprar |
424,387
+80,853
| +24% | +USD 2.84 M | ﹤0.01% | 2462 |
|
|
2022
Q1 | USD 12.8 M | Comprar |
343,534
+127,819
| +59% | +USD 4.92 M | ﹤0.01% | 2607 |
|
|
2021
Q4 | USD 8.59 M | Comprar |
215,715
+173,765
| +414% | +USD 6.65 M | ﹤0.01% | 3113 |
|
|
2021
Q3 | USD 1.56 M | Vender |
41,950
-137,531
| -77% | -USD 5.65 M | ﹤0.01% | 4764 |
|
|
2021
Q2 | USD 7.59 M | Comprar |
179,481
+160,778
| +860% | +USD 6.89 M | ﹤0.01% | 3312 |
|
|
2021
Q1 | USD 885 k | Vender |
18,703
-33,173
| -64% | -USD 1.97 M | ﹤0.01% | 4808 |
|
|
2020
Q4 | USD 3.16 M | Comprar |
51,876
+32,022
| +161% | +USD 1.89 M | ﹤0.01% | 3757 |
|
|
2020
Q3 | USD 927 k | Vender |
19,854
-8,484
| -30% | -USD 418 k | ﹤0.01% | 4260 |
|
|
2020
Q2 | USD 1.44 M | Vender |
28,338
-57,534
| -67% | -USD 2.83 M | ﹤0.01% | 3883 |
|
|
2020
Q1 | USD 3.83 M | Vender |
85,872
-191,059
| -69% | -USD 9.6 M | ﹤0.01% | 2709 |
|
|
2019
Q4 | USD 13.3 M | Comprar |
276,931
+216,665
| +360% | +USD 9.21 M | ﹤0.01% | 2089 |
|
|
2019
Q3 | USD 2.04 M | Comprar |
60,266
+20,336
| +51% | +USD 885 k | ﹤0.01% | 3773 |
|
|
2019
Q2 | USD 1.8 M | Comprar |
39,930
+14,919
| +60% | +USD 589 k | ﹤0.01% | 3854 |
|
|
2019
Q1 | USD 942 k | Vender |
25,011
-74,126
| -75% | -USD 2.49 M | ﹤0.01% | 4154 |
|
|
2018
Q4 | USD 3.4 M | Vender |
99,137
-72,309
| -42% | -USD 2.6 M | ﹤0.01% | 3310 |
|
|
2018
Q3 | USD 8.06 M | Vender |
171,446
-403,743
| -70% | -USD 16.7 M | ﹤0.01% | 2647 |
|
|
2018
Q2 | USD 19.4 M | Vender |
575,189
-36,533
| -6% | -USD 1.14 M | 0.01% | 1673 |
|
|
2018
Q1 | USD 16.6 M | Comprar |
611,722
+478,675
| +360% | +USD 12.1 M | ﹤0.01% | 1844 |
|
|
2017
Q4 | USD 2.22 M | Comprar |
133,047
+29,357
| +28% | +USD 497 k | ﹤0.01% | 3943 |
|
|
2017
Q3 | USD 2.08 M | Vender |
103,690
-473,167
| -82% | -USD 9.26 M | ﹤0.01% | 3845 |
|
|
2017
Q2 | USD 10.6 M | Comprar |
576,857
+501,534
| +666% | +USD 6.76 M | ﹤0.01% | 2130 |
|
|
2017
Q1 | USD 742 k | Vender |
75,323
-219,780
| -74% | -USD 2.66 M | ﹤0.01% | 4592 |
|
|
2016
Q4 | USD 3.22 M | Comprar |
295,103
+263,510
| +834% | +USD 2.76 M | ﹤0.01% | 3441 |
|
|
2016
Q3 | USD 442 k | Comprar |
31,593
+10,085
| +47% | +USD 82 k | ﹤0.01% | 4597 |
|
|
2016
Q2 | USD 151 k | Comprar |
21,508
+10,419
| +94% | +USD 76.4 k | ﹤0.01% | 5063 |
|
|
2016
Q1 | USD 72 k | Comprar |
11,089
+5,578
| +101% | +USD 96.8 k | ﹤0.01% | 5460 |
|
|
2015
Q4 | USD 178 k | Vender |
5,511
-59,862
| -92% | -USD 1.76 M | ﹤0.01% | 5146 |
|
|
2015
Q3 | USD 1.75 M | Comprar |
65,373
+35,027
| +115% | +USD 1.5 M | ﹤0.01% | 3639 |
|
|
2015
Q2 | USD 1.46 M | Comprar |
30,346
+16,116
| +113% | +USD 940 k | ﹤0.01% | 3911 |
|
|
2015
Q1 | USD 866 k | Vender |
14,230
-2,899
| -17% | -USD 177 k | ﹤0.01% | 4238 |
|
|
2014
Q4 | USD 887 k | Comprar |
17,129
+5,791
| +51% | +USD 255 k | ﹤0.01% | 4244 |
|
|
2014
Q3 | USD 499 k | Vender |
11,338
-5,079
| -31% | -USD 159 k | ﹤0.01% | 4574 |
|
|
2014
Q2 | USD 430 k | Comprar |
16,417
+3,763
| +30% | +USD 80.5 k | ﹤0.01% | 4693 |
|
|
2014
Q1 | USD 331 k | Comprar |
12,654
+5,960
| +89% | +USD 160 k | ﹤0.01% | 4832 |
|
|
2013
Q4 | USD 114 k | Comprar |
+6,694
| Nuevas | +USD 118 k | ﹤0.01% | 5307 |
|
Otros fondos que tienen PTCT en su cartera
Posición de Morgan Stanley en PTCT: resumen de T2 2026
Morgan Stanley aumentó su participación en PTC Therapeutics (PTCT) en 64% durante T2 2026, al comprar aproximadamente USD 31 M y elevar la posición a 1,103,675 acciones con un valor de USD 90 M. La posición representa ﹤0.01% de la cartera y ocupa el puesto #1664.
Morgan Stanley reportó por primera vez una posición en PTCT en T4 2013 y la ha mantenido durante 51 trimestres desde entonces. Al cierre de T2 2026, 382 fondos que sigue Wall St. Rank mantienen una posición en PTCT.
- Al cierre de T2 2026, Morgan Stanley tenía 1,103,675 acciones de PTC Therapeutics con un valor de USD 90 M.
- Morgan Stanley compró 429,541 acciones de PTC Therapeutics en T2 2026, por un monto estimado de USD 31 M.
- PTC Therapeutics representó ﹤0.01% de la cartera de Morgan Stanley en T2 2026 y fue su posición número 1664.
- Morgan Stanley reportó por primera vez una posición en PTC Therapeutics en T4 2013 y la ha mantenido durante 51 trimestres desde entonces.
- Al cierre de T2 2026, 382 fondos que sigue Wall St. Rank tenían PTC Therapeutics en cartera.
Según el Informe 13F de Morgan Stanley correspondiente a T2 2026, presentado el 13 ago 2026.